Yleisanestesian-sevofluraani-induktion aiheuttamat EEG-muutokset alle 2-vuotiailla lapsilla - EEG alle 2-vuotiailla

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2007-007583-20-FI

Enrollment

100

Registered

2007-12-21

Start date

2008-01-31

Completion date

Unknown

Last updated

2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tutkittavat ovat terveitä lapsia, joille tehdään kyynelteiden sondeeraus-toimenpide. MedDRA version: 9.1 Level: HLT Classification code 10023621 Term: Lacrimal disorders

Interventions

Trade Name: sevorane Pharmaceutical Form: INN or Proposed INN: SEVOFLURANE CAS Number: 28523866 Trade Name: ilokaasu Pharmaceutical Form: INN or Proposed INN: NITROUS OXIDE CAS Number: 10024972

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026